Intelligence registryBrowse all public records
Public-source dossiershu-xj-39b7b8e79b5b8489e5434ca2347ec90f3cd7dd53
Public source recordorganizationPublic record

Yili Dazhong Pharmaceutical Chain Co., Ltd., the 312th Store in Yining City

Authority: Special Interest RiskCoverage: cnRecord snapshot: 2026-07-06
Evidence class
Public source record
Coverage
cn
Record category
Public record
Record snapshot
2026-07-06
Linked public records

No verified ownership, offshore or transport links have been attached to this record yet.

Source and status notice
Verify the underlying publisher and original record before relying on this information. Always verify the live source record and identifiers before relying on this page.

Compliance Profile

"Public-record notice: Yili Dazhong Pharmaceutical Chain Co., Ltd., the 312th Store in Yining City appears in public source record data. The record is informational and should be checked against the original publisher before legal, financial or counterparty decisions are made."

Banking Impact

This public record does not establish a banking prohibition. Any onboarding or transaction decision should use the original source, a verified identity match and the institution's applicable legal framework.

Legal Status

This is an informational public record, not a sanctions, exclusion or enforcement conclusion unless the page expressly identifies an official issuing authority and record.

Public source metadata

Source: Special Interest Risk
Full Legal NameYili Dazhong Pharmaceutical Chain Co., Ltd., the 312th Store in Yining City
Known aliases伊犁大众医药连锁有限责任公司伊宁市第三百一十二门店
Countries / jurisdictionscn
Source datasets
SHU UYGHUR COMPANIESshu_uyghur_companies
Record statusInformational public record
Record timelineFirst seen: 2024-12-19T21:42:45 • Last seen: 2026-06-05T08:32:11
Risk Topicspoi

Compliance Context Review

Independent assessment

SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for entities seeking to clarify a public record or counterparty signal.

Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Request Risk Assessment
Confidential Review
Report an error or request a correction
Export PDFSubscriber Only